Allogene Therapeutics closes $200.4 million stock offering Apr 16, 2026 04:01PM
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock Apr 16, 2026 04:01PM
Allogene prices $175 million stock offering at $2 per share Apr 14, 2026 09:50PM
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock Apr 14, 2026 09:50PM
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences Jul 12, 2021 08:30AM


Jul 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
Jun 3, 2020 08:30AM Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
Jun 3, 2020 08:30AM Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
Jun 2, 2020 05:50AM Allogene Therapeutics (ALLO) Prices 11.7M Share Common Offering at $47/Sh
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Dec 31, 2019 07:03AM William Blair Sees Biotech M&A Continuing in 2020; Issues Top 10 Predictions
Oct 10, 2019 06:47AM Companies with NDRs 10/10
Oct 9, 2019 06:52AM Companies with NDRs 10/09
Mar 13, 2019 04:07PM William Blair Starts Allogene (ALLO) at Outperform
Feb 5, 2019 08:00AM Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule
Feb 5, 2019 08:00AM Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule